Conference
Increasing treatment time on REMICADE (R) (infliximab) predicts subsequent long-term retention in stable infliximab inflammatory bowel disease patients in Canada
Authors
Marshall JK; Marrache AM; Ewara E
Volume
11
Pagination
pp. S272-S273
Publisher
OXFORD UNIV PRESS
Publication Date
February 1, 2017
Conference proceedings
JOURNAL OF CROHNS & COLITIS
ISSN
1873-9946